Invention Grant
- Patent Title: Xanthine derivative inhibitors of BET proteins
-
Application No.: US16067471Application Date: 2016-12-27
-
Publication No.: US11225481B2Publication Date: 2022-01-18
- Inventor: Xavier Morelli , Sébastien Combes , Jean-Claude Guillemot , Stéphanie Betzi , Yves Collette , Philippe Roche , Adrien Lugari , Sabine Milhas , Brigitt Raux , Iuliia Voitovich
- Applicant: Centre national de la recherche scientifique , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , Université d'Aix-Marseille , Institut Jean Paoli & Irene Calmettes
- Applicant Address: FR Paris; FR Paris; FR Marseilles; FR Marseilles
- Assignee: Centre national de la recherche scientifique,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),Université d'Aix-Marseille,Institut Jean Paoli & Irene Calmettes
- Current Assignee: Centre national de la recherche scientifique,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),Université d'Aix-Marseille,Institut Jean Paoli & Irene Calmettes
- Current Assignee Address: FR Paris; FR Paris; FR Marseilles; FR Marseilles
- Agency: Stites & Harbison, PLLC
- Agent B. Aaron Schulman, Esq.
- Priority: EP15307163 20151229
- International Application: PCT/EP2016/082731 WO 20161227
- International Announcement: WO2017/114843 WO 20170706
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D473/04 ; A61P35/02 ; C07D473/06
Abstract:
This invention relates to xanthine derivative compounds that are inhibitors of BET bromodomains proteins, the method of preparation thereof and applications thereof.
Public/Granted literature
- US20190292186A1 XANTHINE DERIVATIVE INHIBITORS OF BET PROTEINS Public/Granted day:2019-09-26
Information query
